The UK government has said it will introduce long-awaited reforms on social care this year, as part of a new package of measures to reorganise the structure of NHS England.
Many oxygen suppliers have been continuously hostile to innovation that could make delivery more efficient, HBI hears. The pandemic has renewed attention on supply, pricing and patient outcomes leading to some to reassess the approach. HBI speaks to one medical device company that claims to save up to 80% of oxygen for an inpatient.
Piedmont, a region in northwest Italy, has tendered for €213m worth of home oxygen services split over two years, which could boost the market up to 20%.
A detailed draft on German long-term care (LTC) insurance reform is expected in the coming days, HBI hears. The government plans to cap the out-of-pocket spend on residential care to €700 a month, three times less than the current average spend.
The relationship between medtech and its customers is changing. No longer is medtech wheeled out for a one-off purchase. Long-term partnerships are being built, and patients and providers are benefitting. An expert panel at HBI 2020 explored the burgeoning relationship between medtech and services, and some of the challenges this presented.
There is an insatiable demand for unskilled homecare. But is it a sector where it is possible to make money and how? Panellists include: Nimrod Altman, CEO, Natali. This Sino-Israeli group offers a very broad spectrum of services in Israel where it employs 8,000 and also delivers care to 9m Chinese. Benedikt Zacher, Senior Strategist, […]
The COVID-19 pandemic has accelerated the adoption of remote hospital care across Europe and could contribute to up to 20% of hospital care being offered remotely by 2030, according to a new report.
State financing has seen little growth in expenditure in Russia over the last couple of years, while former CIS countries are struggling to fund robust healthcare systems. Despite this, panellists at HBI's Russia and Former CIS - State of the Regions discussion last week found some reasons to be positive.
Netherlands-based medicalised homecare provider and pharmaceutical distributor Mediq is for sale, with a potential €1.2bn price tag. With non-binding bids for the pan-European group due in the first week of November, HBI hears that a private equity buyer is almost certain with little interest from strategic parties.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
